Journal of Movement Disorders

Papers
(The TQCC of Journal of Movement Disorders is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms39
Manganese and Movement Disorders: A Review29
Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers27
Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders19
The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease17
Telemedicine in an Academic Movement Disorders Center during COVID-1917
Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy17
Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy16
The Supplementary Motor Complex in Parkinson’s Disease15
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy15
Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report14
Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?14
Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease14
COVID-19 Associated Acute Necrotizing Encephalopathy Presenting as Parkinsonism and Myorhythmia14
Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria14
Environmental Risk Factors for Progressive Supranuclear Palsy12
Increased Mortality in Young-Onset Parkinson’s Disease12
Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists11
Myoclonus-Ataxia Syndrome Associated with COVID-1910
Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey9
Subjective Cognitive Complaints in Cognitively Normal Patients With Parkinson’s Disease: A Systematic Review9
Management of Parkinson’s Disease in the COVID-19 Pandemic and Future Perspectives in the Era of Vaccination9
Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene8
Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem8
Clinical and Imaging Profile of Patients with Joubert Syndrome7
Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present7
Task-Specific Dystonia in a Professional Billiard Player7
Potential Link Between Cognition and Motor Reserve in Patients With Parkinson’s Disease7
Potential Benefits and Perils of Incorporating ChatGPT to the Movement Disorders Clinic6
The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson’s Disease: A Korean Mendelian Randomization Study6
Automatic Measurement of Postural Abnormalities With a Pose Estimation Algorithm in Parkinson’s Disease6
Labrune’s Syndrome Presenting With Stereotypy-Like Movements and Psychosis: A Case Report and Review6
Minipolymyoclonus: A Critical Appraisal6
Factors Associated with Medication Beliefs in Patients with Parkinson’s Disease: A Cross-Sectional Study5
TNR Gene Mutation in Familial Parkinson’s Disease: Possible Implications for Essential Tremor5
Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for Parkinson’s Disease: Observations from a Single Indian Center5
The Four Square Step Test for Assessing Cognitively Demanding Dynamic Balance in Parkinson’s Disease Patients5
Multiple System Atrophy: Advances in Diagnosis and Therapy5
Focused Vibrotactile Stimulation with Cueing Effect on Freezing of Gait in Parkinson’s Disease: Two Case Reports5
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale5
Umami and Other Taste Perceptions in Patients With Parkinson’s Disease5
GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy5
Long-Term Outcome of Hemimasticatory Spasm4
Constipation is Associated With Mild Cognitive Impairment in Patients With de novo Parkinson’s Disease4
Treatable Ataxias: How to Find the Needle in the Haystack?4
Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease4
The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome4
Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis4
Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia4
A Brief History of NBIA Gene Discovery3
Diagnosis Versus Classification of Essential Tremor: A Research Perspective3
Changes in Cerebral Gray and White Matter in Patients with Pantothenate Kinase-Associated Neurodegeneration: A Long-Term Magnetic Resonance Imaging Follow-Up Study3
Periodic Jaw-Opening Myoclonus in Subacute Sclerosing Panencephalitis3
Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm3
The Case of a Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting with a Prolonged History of Stuttering Speech and a Misdiagnosis of Parkinson’s Disease3
Content Analysis of Korean Videos Regarding Restless Legs Syndrome on YouTube3
A KMT2B Frameshift Variant Causing Focal Dystonia Restricted to the Oromandibular Region After Long-Term Follow-up3
Nearly Abolished Dopamine Transporter Uptake in a Patient With a Novel FBXO7 Mutation3
From Evidence to the Dish: A Viewpoint of Implementing a Thai-Style Mediterranean Diet for Parkinson’s Disease3
Extensive Leukoencephalopathy in Spastic Paraplegia Type 4: Possible Role of Cerebral Autosomal Arteriopathy With Subcortical Infarcts and Leukoencephelopathy3
Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic3
0.029345989227295